Bauerschmitz GJ - Search Results

1

Transductional and transcriptional targeting of adenovirus for clinical applications.

Glasgow JN, Bauerschmitz GJ, Curiel DT, Hemminki A. Glasgow JN, et al. Among authors: bauerschmitz gj. Curr Gene Ther. 2004 Mar;4(1):1-14. doi: 10.2174/1566523044577997. Curr Gene Ther. 2004. PMID: 15032610 Review.

2

Oncolytic adenovirus based on serotype 3.

Hemminki O, Bauerschmitz G, Hemmi S, Lavilla-Alonso S, Diaconu I, Guse K, Koski A, Desmond RA, Lappalainen M, Kanerva A, Cerullo V, Pesonen S, Hemminki A. Hemminki O, et al. Cancer Gene Ther. 2011 Apr;18(4):288-96. doi: 10.1038/cgt.2010.79. Epub 2010 Dec 24. Cancer Gene Ther. 2011. PMID: 21183947 Free article.

3

A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.

Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P, Curiel DT. Stoff-Khalili MA, et al. Among authors: bauerschmitz gj. Gene Ther. 2005 Dec;12(23):1696-706. doi: 10.1038/sj.gt.3302588. Gene Ther. 2005. PMID: 16034451

4

Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents.

Stoff-Khalili MA, Rivera AA, Le LP, Stoff A, Everts M, Contreras JL, Chen D, Teng L, Rots MG, Haisma HJ, Rocconi RP, Bauerschmitz GJ, Rein DT, Yamamoto M, Siegal GP, Dall P, Michael Mathis J, Curiel DT. Stoff-Khalili MA, et al. Among authors: bauerschmitz gj. Cancer Gene Ther. 2006 Jun;13(6):606-18. doi: 10.1038/sj.cgt.7700934. Cancer Gene Ther. 2006. PMID: 16410819

5

Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.

Guse K, Dias JD, Bauerschmitz GJ, Hakkarainen T, Aavik E, Ranki T, Pisto T, Särkioja M, Desmond RA, Kanerva A, Hemminki A. Guse K, et al. Among authors: bauerschmitz gj. Gene Ther. 2007 Jun;14(11):902-11. doi: 10.1038/sj.gt.3302949. Epub 2007 Mar 22. Gene Ther. 2007. PMID: 17377596

6

Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus.

Raki M, Hakkarainen T, Bauerschmitz GJ, Särkioja M, Desmond RA, Kanerva A, Hemminki A. Raki M, et al. Among authors: bauerschmitz gj. Gene Ther. 2007 Oct;14(19):1380-8. doi: 10.1038/sj.gt.3302992. Epub 2007 Jul 5. Gene Ther. 2007. PMID: 17611584

7

Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism.

Volk AL, Rivera AA, Kanerva A, Bauerschmitz G, Dmitriev I, Nettelbeck DM, Curiel DT. Volk AL, et al. Cancer Biol Ther. 2003 Sep-Oct;2(5):511-5. doi: 10.4161/cbt.2.5.440. Cancer Biol Ther. 2003. PMID: 14614316 Free article.

8

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

Bauerschmitz GJ, Lam JT, Kanerva A, Suzuki K, Nettelbeck DM, Dmitriev I, Krasnykh V, Mikheeva GV, Barnes MN, Alvarez RD, Dall P, Alemany R, Curiel DT, Hemminki A. Bauerschmitz GJ, et al. Cancer Res. 2002 Mar 1;62(5):1266-70. Cancer Res. 2002. PMID: 11888888

9

The flt-1 promoter for transcriptional targeting of teratocarcinoma.

Bauerschmitz GJ, Nettelbeck DM, Kanerva A, Baker AH, Hemminki A, Reynolds PN, Curiel DT. Bauerschmitz GJ, et al. Cancer Res. 2002 Mar 1;62(5):1271-4. Cancer Res. 2002. PMID: 11888889

10

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.

Kanerva A, Wang M, Bauerschmitz GJ, Lam JT, Desmond RA, Bhoola SM, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A. Kanerva A, et al. Among authors: bauerschmitz gj. Mol Ther. 2002 Jun;5(6):695-704. doi: 10.1006/mthe.2002.0599. Mol Ther. 2002. PMID: 12027553 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters